Page 7 - Drug Makers In India

PIL in HC seeks permission for sale of Remdesivir in domestic markets

A PIL in the Delhi High Court has urged it to direct the Centre to permit sale of Remdesivir, used in Covid-19 treatment, by those pharmaceutical companies which manufacture it solely for the purpose

Shelf life of vaccines likely to be more than 3 months, unlike drugs

They have the stability data for these investigational products, said a source

Govt revises PLI scheme for bulk drugs to boost local manufacturing

Industry says revised PLI scheme will attract more MSMEs to invest as minimum investment clause done away with

PE firm PAG-led group to buy pharma firm Anjan Drug for undisclosed sum

Target company makes and supplies active pharmaeutical ingredients in the central nervous system space to some of the world's largest drug makers

Alembic Pharma sees domestic business growing in double digits this fiscal

Strong brand recall, an efficient sales force, a growing network of supportive doctors and timely product launches are the key catalysts for this business

Glenmark Pharma gets nod to launch favipiravir for Covid-19 patients

Glenmark is conducting phase-3 clinical trials; drug has got restricted emergency use

HCQ's emergency use revocation by US may not hit India's exports

This is because while emergency-use authorisation for treating Covid-19 was a recent move, the drug has been used since years for rheumatoid arthritis and lupus

With little access to doctors, drug firms go digital to stay relevant

The rise of e-pharmacies and tele-consultations during Covid-19 has made it easier for healthcare companies to access patient pools

Dr Reddy's inks pact with Gilead to manufacture, market Remdesivir in India

Dr Reddy's would need to scale up manufacturing and obtain regulatory approval for marketing of this drug in respective countries, the company said

Gilead finds fourth partner for manufacture of Remdesivir in Zydus Cadila

Indian drug maker to get know-how from Gilead Sciences Inc, to manufacture the API for Remdesivir, make the finished product and market it in 127 countries, including India

Revised Wockhardt deal boosts prospects of Dr Reddy's India business

The company, according to its new strategy, is focusing on growing its India-based branded products

Lupin recieves USFDA nod to market generic anthelmintic tablets

According to IQVIA MAT April 2020 data, Albendazole tablets had an annual sales of around $34 million in the US, Lupin said

Joint inflammation drug may be repurposed to treat Covid-19: EMBO Study

According to the study, baricitinib also helped reduce the quantity of the novel coronavirus in infected cells

Hyderabad's Raghav Life Sciences develops Favipiravir for Covid-19 patients

Firm says it has been in talks with at least eight buyers, including a few overseas companies, to supply the anti-retroviral drug

Strong Q4 performance, debt reduction show Aurobindo Pharma in good health

Despite an over 150 per cent rise since March lows, the stock can see more gains

FDA new drug approval run rate down in FY20 for most Indian pharma majors

According to analysts, companies are skeptical about entering crowded opportunities

Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business

The company has registered 10% growth in revenues at Rs 4,431.8 cr for the quarter under review from Rs 4,016.6 cr in the year-ago period

Covid-19 lockdown: After April shock, drug sales improve in May

Till May 15, the overall inventory was 39 days, compared to 43 days in first half of the previous month

Coronavirus outbreak: India plans ayurvedic trials on patients soon

On the preventive front, many states, including Haryana, Goa and Kerala, have started using ayurvedic medicines for asymptomatic patients and even frontline workers.

India's only quinine making unit set up in 1874, has been shut since 2001

Covid-19 has triggered a sense of urgency to revive this sick unit, as Hydroxychloroquine, an anti-malarial drug, surfaced as potential medicine to alleviate the symptoms of the disease